TITLE

Selective reduction of amyloid β42 discriminates Alzheimer's disease from Huntington's disease: indication for distinct pathological events in amyloid β peptide aggregation

AUTHOR(S)
Mollenhauer, B.; Bibl, M.; Esselmann, H.; Steinacker, P.; Trenkwalder, C.; Brechlin, P.; Wiltfang, J.; Otto, M.
PUB. DATE
October 2006
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Oct2006, Vol. 77 Issue 10, p1201
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the distinction between Huntington's disease and Alzheimer's disease. Both are neurodegenerative disorders associated with the aggregation of misfolded polypeptides that result to amyloids and neuronal damage. Huntington's disease is brought by the expanded glutamine repeats that encode polyglutamine tracts of the gene encoding the huntingtin protein. On the other hand, extracellular amyloid peptides β form amyloid plaques in the brain in Alzheimer's disease.
ACCESSION #
22853885

 

Related Articles

  • COMMUNICATIVE RESPONSIBILITY AND SEMANTIC TASK IN THE LANGUAGE OF ADULTS WITH DEMETIA. Goldfarb, Robert; Goldberg, Elmera // Perceptual & Motor Skills;Jun2004 Part 2, Vol. 98 Issue 3, p1177 

    A probe technique requiring convergent and divergent semantic behavior and representing five levels of communicative responsibility served as the research tool. Stimuli were presented to adults identified as having Alzheimer disease or multi-infarct dementia. Within each group differences were...

  • A Neurotoxic Phosphoform of Elk-1 Associates with Inclusions from Multiple Neurodegenerative Diseases. Sharma, Anup; Callahan, Linda M.; Jai-Yoon Sul; Kim, Tae Kyung; Barrett, Lindy; Minsun Kim; Powers, James M.; Federoff, Howard; Eberwine, James // PLoS ONE;2010, Vol. 5 Issue 2, p1 

    Neurodegenerative diseases are characterized by a number of features including the formation of inclusions, early synaptic degeneration and the selective loss of neurons. Molecules serving as links between these shared features have yet to be identified. Identifying candidates within the...

  • Comprehensive mRNA Expression Profiling Distinguishes Tauopathies and Identifies Shared Molecular Pathways. Bronner, Iraad F.; Bochdanovits, Zoltán; Rizzu, Patrizia; Kamphorst, Wouter; Ravid, Rivka; van Swieten, John C.; Heutink, Peter // PLoS ONE;2009, Vol. 4 Issue 8, p1 

    Background: Understanding the aetiologies of neurodegenerative diseases such as Alzheimer's disease (AD), Pick's disease (PiD), Progressive Supranuclear Palsy (PSP) and Frontotemporal dementia (FTD) is often hampered by the considerable clinical and molecular overlap between these diseases and...

  • Diabetes Mellitus and Risk of Alzheimer's Disease and Dementia with Stroke in a Multiethnic Cohort. Luchsinger, Jose A.; Ming-Xin Tang; Stern, Yaakov; Shea, Steven; Mayeux, Richard // American Journal of Epidemiology;Oct2001, Vol. 154 Issue 7, p635 

    Research on the relation between diabetes mellitus and dementia has produced conflicting results, and the relation has not been investigated among Blacks and Hispanics. In this study, Cox proportional hazards models were used to analyze longitudinal data from 1,262 elderly subjects without...

  • Can aerobic exercise protect against dementia? Graff-Radford, Neill R. // Alzheimer's Research & Therapy;2011, Vol. 3 Issue 1, p1 

    There are more than 36 million people in the US over the age of 65, and all of them are impacted by the cognitive decline and brain atrophy associated with normal aging and dementia-causing conditions like Alzheimer's disease, Lewy body disease, and vascular dementia. Recently, moderate exercise...

  • What can we learn from study of Alzheimer's disease in patients with Down syndrome for early-onset Alzheimer's disease in the general population? Wallace, Robyn A.; Dalton, . Dalton // Alzheimer's Research & Therapy;2011, Vol. 3 Issue 2, p72 

    The clinical and scientific study of dementia in adults with Down syndrome led to the development of the amyloid hypothesis as a fundamental concept in Alzheimer's disease pathogenesis. The journey started with the discovery of the structure and metabolic processing of β-amyloid brain...

  • Alzheimer Disease. Cummings, Jeffrey L.; Cole, Greg // JAMA: Journal of the American Medical Association;5/8/2002, Vol. 287 Issue 18, p2335 

    Focuses on alzheimer disease, a progressive neurodegenerative disorder. Incidence, prevalence, and economic impact; Clinical diagnosis; Pathology; Molecular genetics and pathogenesis; Treatments, including cholinesterase inhibitors.

  • Filling the Gaps in the Aβ Cascade Hypothesis of Alzheimer's Disease. Golde, Todd E.; Dickson, Dennis; Hutton, Michael // Current Alzheimer Research;Dec2006, Vol. 3 Issue 5, p421 

    Advances in the understanding of Alzheimer's disease (AD) pathogenesis provide strong support for a modified version of the amyloid cascade hypothesis, which is now often referred to as the amyloid β protein (Aβ) cascade hypothesis. The basic tenant of this modified hypothesis is that...

  • Mutant ubiquitin and p62 immunoreactivity in cases of combined multiple system atrophy and Alzheimer’s disease. Terni, Beatrice; Rey, María Jesús; Boluda, Susana; Torrejón-Escribano, Benjamín; Sabate, M. Pujol; Calopa, Matil; van Leeuwen, Fred W.; Ferrer, Isidro // Acta Neuropathologica;Apr2007, Vol. 113 Issue 4, p403 

    Recent studies have shown the co-existence of α-synuclein and phosphorylated tau (pTau) in several neurodegenerative diseases. Here, we report two autopsy cases of combined multiple system atrophy (MSA) and Alzheimer’s disease (AD). In both cases, abundant α-synuclein-positive glial...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics